Oxybutynin Chloride
- Product NDC
- 70518-2640
- 11-digit product format
- 705182640
- Labeler code
- 70518
- Product ID
- 70518-2640_4a7c6cdc-4b20-7a2a-e063-6294a90aaea2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxybutynin Chloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA209335
- Marketing category
- ANDA
- Marketing start
- 2020-03-26
- Substance
- OXYBUTYNIN CHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Oxybutynin Chloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OXYBUTYNIN CHLORIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | L9F3D9RENQ |
| Rxcui | 863664 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 70518-2640-0 | 2022-01-31 | C162847 | 48780-1 | d6a99b39-b1a4-a426-e053-dadaa90af4c2 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 70518-2640-1 | 2022-01-31 | C162847 | 48780-1 | d6a99b39-b1a4-a426-e053-dadaa90af4c2 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 70518-2640-2 | 2022-01-31 | C162847 | 48780-1 | d6a99b39-b1a4-a426-e053-dadaa90af4c2 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 70518-2640-3 | 2022-01-31 | C162847 | 48780-1 | d6a99b39-b1a4-a426-e053-dadaa90af4c2 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 70518-2640-0 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-b1a4-a426-e053-dadaa90af4c2 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 70518-2640-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-b1a4-a426-e053-dadaa90af4c2 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 70518-2640-2 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-b1a4-a426-e053-dadaa90af4c2 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 70518-2640-3 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-b1a4-a426-e053-dadaa90af4c2 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70518-2640-0 | Oxybutynin Chloride | 30 in 1 BLISTER PACK | TABLET | 30 | | 9 |
| 70518-2640-1 | Oxybutynin Chloride | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | | 9 |
| 70518-2640-2 | Oxybutynin Chloride | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 9 |
| 70518-2640-3 | Oxybutynin Chloride | 180 in 1 BOTTLE, PLASTIC | TABLET | 180 | | 9 |
| 70518-2640-4 | Oxybutynin Chloride | 30 in 1 BLISTER PACK | TABLET | 30 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2640 | OXYBUTYNIN CHLORIDE TABLET [REMEDYREPACK INC.] | 7 | Current NDC, Legacy NDC, 5 package rows | 20250104_1a08a16a-f16d-4ef1-95bb-6943bcae0737.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2640-0 | 70518264000 | 30 TABLET in 1 BLISTER PACK (70518-2640-0) | 30 tablet | 2020-03-26 | 0000-00-00 | No | No | Current |
| 70518-2640-1 | 70518264001 | 60 TABLET in 1 BOTTLE, PLASTIC (70518-2640-1) | 60 tablet | 2020-03-26 | 0000-00-00 | No | No | Current |
| 70518-2640-2 | 70518264002 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-2640-2) | 90 tablet | 2020-06-11 | 0000-00-00 | No | No | Current |
| 70518-2640-3 | 70518264003 | 180 TABLET in 1 BOTTLE, PLASTIC (70518-2640-3) | 180 tablet | 2020-06-11 | 0000-00-00 | No | No | Current |
| 70518-2640-4 | 70518264004 | 30 in 1 BLISTER PACK | | | | | | Historical |